Furthermore, in a mouse xenograft model, cell lines with reduced CAVIII expression reduced tumor growth, hemoglobin concentration, and angiogenesis, suggesting that CAVIII/miR16-5/VEGFA may be a new target for the treatment of colorectal cancer. The gene discussed is VEGFA; the disease is neoplasm.